We have redirected you to the United States (US Español) site. If you believe this is in error, you can change your selection.

Bulkamid for You
Profesionales médicos
Contacto

To access this area you must be a Healthcare Professional.

I am not a Healthcare Professional

Datos clínicos

El extenso perfil clínico de Bulkamid lo ha convertido en un producto de confianza para médicos y pacientes en todo el mundo.

Datos publicados

Ensayos en curso

Para usted
¿Qué es la IUE?
Learn More
Compare tratamientos
Estudios de casos
Preguntas frecuentes
Recursos

Profesionales médicos
Profesionales médicos
Datos clínicos
Professional Resources
Learn More

Bulkamid
Contacto
Política de privacidad
Información de seguridad importante
Bulkamid Incident Form
Bulkamid Incident Form (OUS)

Choose your region and language

1. Chapple C, Dmochowski R., Particulate Versus Non-Particulate Bulking Agents in the Treatment of Stress Urinary Incontinence. Res Rep Urol. 2019; 11: 299-310.

2. Itkonen-Freitas AM et al. Tension free vaginal tape vs polyacrylamide hydrogel injection for primary stress urinary incontinence: a randomised controlled trial, J Urol. Feb. de 2020. Vol. 203, 372-378.

3. Brosche T, et al., Seven‐year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence, Journal of Neurology and Urodynamics, 2021;40:502-8.

4. Toozs-Hobson P, Al-Singary W, Fynes M, Tegerstedt G, Lose G. Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress-predominant mixed incontinence. Int Urogynecol J., oct. de 2012; 23(10):1373-8. Epub, 25 de abril de 2012.

5. Sokol ER, Karram MM, Dmochowski R. Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study. J Urol. Sep. de 2014;192(3):843-9.

6. Pai A, Al-Singary W. Durability, safety and efficacy of polyacrylamide hydrogel (Bulkamid®) in the management of stress and mixed urinary incontinence: three year follow up outcomes. Cent European J Urol. 2015; 68(4): 428-433.

7. Andrews et al. Bulkamid® – does the volume injected affect outcome? IUGA 2015, póster.

8. Marthaler C, et al., Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome? Int Urogynecol J., nov. de 2017; 28(11):1657-1661. doi: 10.1007/s00192-017-3332-5. Epub, 17 de abril de 2017.

9. Zivanovic I, Rautenberg O, Lobodasch K, Von Bünau G, Walser C, Viereck V. Urethral bulking for recurrent stress urinary incontinence after mid urethral sling failure. Neurol Urodynam, 31 de marzo de 2016.

10. Datos analizados en Dwyer et al., "Voice your choice": A study of women's choice of surgery for primary stress urinary incontinence, International Urogynecology Journal (2020) 31:769-777.